Morgan Stanley’s Tenaya Therapeutics TNYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $70.8K | Sell |
115,879
-198,670
| -63% | -$121K | ﹤0.01% | 6244 |
|
|
2025
Q1 | $179K | Sell |
314,549
-1,173,757
| -79% | -$669K | ﹤0.01% | 5774 |
|
|
2024
Q4 | $2.13M | Buy |
1,488,306
+1,175,315
| +376% | +$1.68M | ﹤0.01% | 4651 |
|
|
2024
Q3 | $604K | Buy |
312,991
+135,268
| +76% | +$261K | ﹤0.01% | 5310 |
|
|
2024
Q2 | $551K | Sell |
177,723
-138,166
| -44% | -$428K | ﹤0.01% | 5248 |
|
|
2024
Q1 | $1.65M | Sell |
315,889
-148,123
| -32% | -$775K | ﹤0.01% | 4690 |
|
|
2023
Q4 | $1.5M | Buy |
464,012
+379,989
| +452% | +$1.23M | ﹤0.01% | 5101 |
|
|
2023
Q3 | $214K | Sell |
84,023
-28,344
| -25% | -$72.3K | ﹤0.01% | 5551 |
|
|
2023
Q2 | $660K | Buy |
112,367
+31,948
| +40% | +$188K | ﹤0.01% | 5078 |
|
|
2023
Q1 | $229K | Buy |
80,419
+52,559
| +189% | +$150K | ﹤0.01% | 5652 |
|
|
2022
Q4 | $56K | Buy |
27,860
+13,601
| +95% | +$27.3K | ﹤0.01% | 6244 |
|
|
2022
Q3 | $41K | Buy |
14,259
+1,158
| +9% | +$3.33K | ﹤0.01% | 6494 |
|
|
2022
Q2 | $75K | Buy |
13,101
+1,564
| +14% | +$8.95K | ﹤0.01% | 6414 |
|
|
2022
Q1 | $135K | Sell |
11,537
-18,661
| -62% | -$218K | ﹤0.01% | 6137 |
|
|
2021
Q4 | $572K | Buy |
30,198
+27,132
| +885% | +$514K | ﹤0.01% | 5464 |
|
|
2021
Q3 | $63K | Buy |
+3,066
| New | +$63K | ﹤0.01% | 6612 |
|